BTG PLC (BTG.L)
19 Jun 2013
|Market Cap (Mil.):||£1,337.46|
|Shares Outstanding (Mil.):||360.50|
LONDON - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion.
* Buys EKOS Corp, Nordion unit for combined initial $380 mln
LONDON, May 23 - BTG PLC : * Proposed acquisition of therasphere * To buy the targeted therapies division of nordion, for approximately US$200
LONDON, May 23 - BTG PLC : * Acquisition of ekos * Has entered into an agreement to buy ekos corporation for an initial cash of
LONDON - BTG's Varisolve treatment for varicose veins has been accepted for review by the U.S. Food and Drug Administration, putting it on track for potential approval and launch during the first half of 2014.
LONDON, April 12 - Speciality pharmaceutical company BTG said on Friday its Varisolve treatment for varicose veins has been accepted for review by the U.S. Food & Drug Administration (FDA) and could be approved and launched during the first half of 2014.
LONDON, April 4 - BTG PLC : * Delivered a strong financial performance and has achieved its key business
LONDON, Feb 4 - BTG PLC : * Varisolve nda submitted to the FDA
LONDON, Jan 31 - BTG PLC : * Anticipates FY revenues for year to 31 March 2013 will be around the top end
The U.S. beef operations of Brazil-based meatpacker JBS SA could post better-than-expected profit margins in 2013 after Cargill decided to idle its beef processing plant in Plainview, easing pressure on cattle costs, analysts at BTG Group told clients in a note.
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
BTG PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.